1. Volume 150, Issue 3, Pages 597-605 (September 2016)
Variation in Warfarin Use at Hospital Discharge After Isolated Bioprosthetic Mitral Valve Replacement 
Thomas A. Schwann, MD, Robert H. Habib, PhD, Rakesh M. Suri, MD, J. Matthew Brennan, MD, Xia He, MA, Vinod H. Thourani, MD, Milo Engoren, MD, Gorav Ailawadi, MD, Brian R. Englum, MD, Mark R. Bonnell, MD, James S. Gammie, MD 
CHEST 
Volume 150, Issue 3, Pages (September 2016)
DOI: /j.chest
Copyright © 2016 American College of Chest Physicians Terms and Conditions

2. Figure 1
Distribution of warfarin use across hospitals; A, All hospitals (N = 886). B, Hospitals with > 10 bioprosthetic mitral valve replacement (BMVR) cases annually (n = 245).
CHEST  , DOI: ( /j.chest )
Copyright © 2016 American College of Chest Physicians Terms and Conditions

3. Figure 2
Distribution of discharge warfarin rates across surgeons. A, All surgeons (N = 1,774). B, Surgeons with > 10 mitral valve replacement (MVR) cases annually (n = 172).
CHEST  , DOI: ( /j.chest )
Copyright © 2016 American College of Chest Physicians Terms and Conditions